Enteric Hyperoxaluria
9 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, and Pharmacodynamics of SYNB8802v1 in Subjects With History of Gastric Bypass Surgery or Short-bowel Syndrome (NCT05377112) | Synlogic | 2022-03-29 |
| Safety and Tolerability of SYNB8802 in Healthy Adult Volunteers and Adult Subjects With Enteric Hyperoxaluria (NCT04629170) | Synlogic | 2020-11-04 |
| Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria (NCT03847090) | Allena Pharmaceuticals | 2019-08-26 |
| Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia (NCT03391804) | Allena Pharmaceuticals | 2018-07-17 |
| Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria (NCT03456830) | Allena Pharmaceuticals | 2018-05-21 |
| Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria (NCT00588120) | Mayo Clinic | 1998-12-01 |
Track Enteric Hyperoxaluria automatically
Every clearance here is in the API, with alerts when new ones post.